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Background: Lysine plays an important role in Streptomyces clavuligerus metabolism; it takes part in its catabolism, via
cadaverine, and in its secondary metabolism, in which lysine is converted via 1-piperideine-6-carboxylate to
alpha-aminoadipic acid, a beta-lactam antibiotic precursor. The role of lysine as an enhancer of cephamycin C production,
when added to production medium at concentrations above 50 mmol l-1, has already been reported in the literature,
with some studies attributing a positive influence to multifunctional diamines, among other compounds. However,
there is a lack of research on the combined effect of these compounds on antibiotic production.
Results: Results from experimental design-based tests were used to conduct response surface-based optimization studies
in order to investigate the synergistic effect of combining lysine with cadaverine, putrescine, 1,3-diaminopropane, or
alpha-aminoadipic acid on cephamycin C volumetric production. Lysine combined with cadaverine influenced
production positively, but only at low lysine concentrations. On the whole, higher putrescine concentrations (0.4 g l-1)
affected negatively cephamycin C volumetric production. In comparison to culture media containing only lysine as
additive, combinations of this amino acid with alpha-aminoadipic acid or 1,3-diaminopropane increased cephamycin C
production by more than 100%.
Conclusion: This study demonstrated that different combinations of lysine with diamines or lysine with
alpha-aminoadipic acid engender significant differences with respect to antibiotic volumetric production, with
emphasis on the benefits observed for lysine combined with alpha-aminoadipic acid or 1,3-diaminopropane.
This increase is explained by mathematical models and demonstrated by means of bioreactor cultivations. Moreover, it
is consistent with the positive influence of these compounds on lysine conversion to alpha-aminoadipic acid, a
limiting step in cephamycin C production.
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The commercial importance of the actinomycete Strepto-
myces clavuligerus lies in its ability to produce several
secondary metabolites of therapeutic interest [1]. Among
these compounds are: cephamycin C, a beta-lactam anti-
biotic more resistant to beta-lactamases than the struc-
turally similar antibiotic cephalosporin C produced by
filamentous fungi, and for this reason used as raw material
for production of semi-synthetic antibiotics (cefotetan,
cefoxitin, cefmetazole, and temocillin) [2,3]; clavulanic* Correspondence: mlaraujo@iq.unesp.br
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reproduction in any medium, provided the oracid, a beta-lactamases inhibitor whose use in conjunction
with amoxicillin is the most important commercial ex-
ample [4]; other clavams, which have antifungal properties
[5]; and non-beta-lactam compounds such as holomycin
and tunicamycin, which have antibiotic and antitumor
properties [5-7]. The biosynthetic diversity inherent to
S. clavuligerus results in extremely complex metabolic
regulation [8-14], which has led to different studies aimed
at increasing the biosynthesis of relevant biocompounds.
Among these compounds, cephamycin C has been one of
the most extensively investigated [15-23]. The basic struc-
ture of this biocompound and of all other beta-lactam an-
tibiotics produced by prokaryotes or eukaryotes derives
from L-cysteine, L-valine, and L-alpha-aminoadipic acid.d. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lysine degradation via 1-piperideine-6-carboxylate [24-26].
The use of exogenous lysine to enhance cephamycin C
biosynthesis in cultures of producer species has been
known for over thirty years [16,20,23,27,28]. Studies have
shown that high lysine concentrations (above 50 mmol l-1)
promote higher cephamycin C production as com-
pared to that of culture media containing little or no
lysine. Researchers have obtained increases of up to
300% in cephamycin C production by S. clavuligerus in
a culture medium containing about 100 mmol l-1 of lysine
[14,20,21]. In spite of lysine degradation via 1-piperideine-
6-carboxylate pathway producing the precursor alpha-
aminoadipic acid [25,26], complete lysine catabolism
occurs via cadaverine [24,29,30]. Cadaverine and other
diamines, such as diaminopropane and putrescine, pro-
mote beta-lactam antibiotic production in Nocardia
lactamdurans or S. clavuligerus [31-34]. Nevertheless, it
is difficult to determine the extent to which these com-
pounds influence antibiotic biosynthesis, since diamines
act as modulators of several cell functions [32,33,35].
Thus, there is scarce quantitative research on the use of
lysine combined with other diamines or other com-
pounds that can potentially enhance beta-lactam anti-
biotic production in S. clavuligerus [16,23,33]. This was
explored in this study, which investigates increases in
cephamycin C production by adding cadaverine, putres-
cine, 1,3-diaminopropane or alpha-aminoadipic acid in
culture media containing lysine as compared to those
obtained in culture media containing lysine alone. Cul-
tivations were performed in accordance with a central
composite-based, face-centered experimental design (CCF)
whereas concentrations of lysine combined with every
compound were optimized using Response Surface
Methodology. Best conditions were validated by means




Streptomyces clavuligerus ATCC 27064 was stored in the
form of spore suspension (approximately 108 spores ml-1)
at −80°C in 2 ml cryotube vials (glycerol at 20% w v-1).
Escherichia coli ESS 2235 supersensitive to beta-lactam
antibiotics was employed as test organism. The strain was
cultivated in nutrient agar medium (Difco™ Nutrient Agar)
at 37°C for 24 hours. The cells were stored at −80°C in
2 ml cryotube vials.
Culture media
The seed medium contained (g l-1) tryptone (5.0), yeast
extract (3.0), malt extract (10), and buffering agent 3-
(N-morpholine) propanesulfonic acid (MOPS) (21). The
inoculum medium consisted (g l-1) of soluble starch (10),cotton seed extract (PROFLO® - Traders Protein, USA)
(8.5), yeast extract (1.0), K2HPO4 (0.80), MgSO4.7H2O
(0.75), MOPS (21), and 10 ml of salt solution per l of
medium. The salt solution contained (g l-1) MnCl2.4H2O
(1.0), FeSO4.7H2O (1.0), and ZnSO4.7H2O (1.0). The basal
production medium contained (g l-1) soluble starch (10),
PROFLO® (8.5) boiled down and filtered (using a vacuum
pump), yeast extract (0.50), K2HPO4 (1.75), MgSO4.7H2O
(0.75), CaCl (0.20), NaCl (2.0), MOPS (21), the aforemen-
tioned salt solution (5.0 ml l-1), and sodium thiosulfate
(1.0) added at 30 h after inoculation according to Inamine
and Birnbaum [31]. The initial pH of culture media was
fitted to 6.8 ± 0.1. The proportion of filtered PROFLO®
nitrogen corresponded to 40% of gross PROFLO®.
In order to investigate the influence of different com-
pounds on cephamycin C biosynthesis, the production
medium was supplemented with lysine, alpha-aminoadipic
acid, and diamines 1,3-diaminopropane, putrescine, and
cadaverine. These compound concentrations were estab-
lished according to the purpose of each experiment.
Experimental procedure
Spore germination and inoculum preparation consisted of
two pre-cultures with 24-hour cultivation each in shake
flasks. Inoculum volume comprised 10% of suspension
cell volume per culture medium volume throughout this
study. Submerged cultures for cephamycin C production
were performed in 500 ml Erlenmeyer shake flasks at 28°C
and 260 rpm (5 cm eccentricity). To prevent problems of
oxygen limitation during the shake-flask procedure, the
broth volume was kept under 10% of the Erlenmeyer
flask nominal volume. Samples were collected at 24-hour
intervals. Experiments in the bench-scale bioreactor
(New Brunswick Bioflo 2000; 5 l working volume) were
performed at 1.0 vvm aeration rate, 6.8 ± 0.1 pH, 28°C
temperature, and 50% dissolved oxygen saturation level
automatically controlled by varying the agitation speed.
Analytical methods
The supernatant was obtained after centrifugation of the
culture medium at 15,550 x g for 10 min, 4°C, for further
analyses. The cell density was quantified as grams of dry
weight per liter of sample (gDWC l-1). Cephamycin C was
determined by means of the agar-diffusion assay method
using cephalosporin C zinc salt (Sigma) as standard.
Penase® (BD Difco) was employed at 20 μL per ml of sam-
ple, reacting at 25°C for 20 min to degrade penicillin N. In
this method, the measure of cephamycin C represents the
total amount of cephalosporins in the sample (in mg l-1)
[36]. A calibration curve was performed using ten ceph-
alosporin C concentration values from 5 to 120 mg l-1 and
24 replicates for each concentration. Antibiotic analyses
were also carried out via high-performance liquid chroma-
tography as described in Baptista Neto et al. [37]. Lysine
Table 2 Range and levels of independent variables lysine (Ly
putrescine (Put), in coded and original units, according to tw





Original units (g l-1)
Lys + 1,3
Run xLys xi xLys x1,3D xCad xPut Measured*
1 −1 −1 0.0 0.0 0.0 0.0 18.1 ± 3.0
2 0 −1 3.7 0.0 0.0 0.0 45.6 ± 7.2
3 +1 −1 7.4 0.0 0.0 0.0 72.3 ± 4.1
4 −1 0 0 2.5 3.5 0.2 47.6 ± 3.9
5 0 0 3.7 2.5 3.5 0.2 108.9 ± 0.0
6 0 0 3.7 2.5 3.5 0.2 122.1 ± 0.0
7 0 0 3.7 2.5 3.5 0.2 100.7 ± 0.0
8 0 0 3.7 2.5 3.5 0.2 120.0 ± 0.0
9 +1 0 7.4 2.5 3.5 0.2 114.4 ± 13.6
10 −1 +1 0 5.0 7.0 0.4 62.2 ± 2.6
11 0 +1 3.7 5.0 7.0 0.4 125.3 ± 0.8
12 +1 +1 7.4 5.0 7.0 0.4 140.2 ± 8.0
*The cultivations were performed in triplicate, with the exception of cultivation at c
Table 1 Range and levels of the independent variables
lysine (Lys) and alpha-aminoadipic acid (AAA), in coded
and original units, according to the two-factor, three-level
central-composite-based, face-centered, experimental
design (CCF); the response variable is cephamycin
C concentration (CephC) obtained at 72-hour cultivation
Run Independent variables Response
Coded units Original units (g l-1) CephC (mg l-1)
xLys xAAA xLys xAAA Measured* Predicted
1 −1 −1 0.9 0 25.0 ± 8.2 15.5
2 0 −1 3.2 0 45.0 ± 9.6 52.7
3 +1 −1 5.5 0 55.0 ± 5.9 56.7
4 −1 0 0.9 0.32 44.1 ± 0.9 57.8
5 0 0 3.2 0.32 105.8 ± 6.6 100.5
6 +1 0 5.5 0.32 118.5 ± 6.4 110.0
7 0 +1 3.2 0.64 112.4 ± 0.0 110.6
8 0 +1 3.2 0.64 102.8 ± 0.0 110.6
9 0 +1 3.2 0.64 117.8 ± 0.0 110.6
10 0 +1 3.2 0.64 112.0 ± 0.0 110.6
11 −1 +1 0.9 0.64 66.7 ± 7.7 62.4
12 +1 +1 5.5 0.64 118.8 ± 9.6 125.6
*The cultivations were performed in triplicate, with the exception of
cultivation at condition (0,+1) performed in quadruplicate; SD = standard
deviation.
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means of the post-column derivatization method with
orthophtalaldehyde and quantified in a fluorescence de-
tector [38]. The starch concentration was determined after
acid hydrolysis, by quantifying the total reducing sugars by
the dinitrosalicylic acid method [39].
Experimental design
CCF experimental designs, including four replicates of an
experiment under the same conditions, were employed to
investigate individual and combined effects of lysine and
compounds, one at a time, putrescine, 1,3-diaminopro-
pane, cadaverine, and alpha-aminoadipic acid, on cepha-
mycin C production. The response surface methodology
was used to investigate the relationship between cephamy-
cin C production (response variable) and the compounds
that enhance beta-lactam antibiotic production (independ-
ent variables) [40,41]. The chosen experimental design
and the established concentration limits of the compounds
under investigation (independent variables) were appro-
priate for adjusting models represented by second-order
polynomials according to the following equation:
y^ ¼ a0 þ a1xLys þ aixi þ a11x2Lys þ aiix2i þ a1ixLysxi
where y^ represents the dependent variable, cephamycin
C production (mg l-1), a0 is the interception coefficient
(average value of cephamycin C, in mg l-1), x represents
the independent variables in coded unities: xLys = lysine,
and xi represents the other compounds studied (i = alpha-s), 1,3-diaminopropane (1,3D), cadaverine (Cad), and
o-factor, three-level central-composite-based,
ble is cephamycin C concentration (CephC) obtained at
Response
CephC (mg l-1)
D Lys + Cad Lys + Put
Predicted Measured* Predicted Measured* Predicted
10.6 19.0 ± 2.7 22.7 18.0 ± 2.7 16.7
59.9 45.6 ± 2.2 39.1 47.3 ± 3.2 53.9
64.9 72.1 ± 1.9 74.7 75.5 ± 3.6 70.3
53.9 34.7 ± 3.5 30.2 31.1 ± 2.2 33.8
109.2 40.5 ± 0.0 41.2 63.1 ± 0.0 64.6
109.2 35.9 ± 0.0 41.2 75.0 ± 0.0 64.6
109.2 42.0 ± 0.0 41.2 69.0 ± 0.0 64.6
109.2 41.1 ± 0.0 41.2 64.9 ± 0.0 64.6
120.2 74.2 ± 2.1 71.5 64.0 ± 3.4 74.7
62.4 47.1 ± 2.8 47.9 29.1 ± 2.5 27.5
123.7 54.1 ± 0.2 53.5 44.9 ± 2.9 51.9
140.7 78.8 ± 0.5 78.5 61.1 ± 1.9 55.6
ondition (0,0) performed in quadruplicate; SD = standard deviation.
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cine); a1 and ai are the linear terms, a11 and aii are the
quadratic terms, a1i is the interaction term. Statistica soft-
ware (7.0 version) was used for regression and graphical
analyses of experimental data.
The conditions of independent variables and cephamycin
C production results (observed and predicted) are shown
in Tables 1 and 2.
Results and discussion
Individual effect of diamines and precursors on
cephamycin C production
For this study, two concentrations for each diamine were
defined based on literature data obtained for other beta-
lactam antibiotic producing microorganisms [32,33,35,42].
Cephamycin C biosynthesis precursors lysine and alpha-
aminoadipic acid were tested at several concentrations in
























































Figure 1 Effect of biomass and cephamycin C with different diamines
production (C) obtained in shake-flasks cultivations of basal medium with n
with putrescine (Put), 1,3-diaminopropane (1,3D), and cadaverine (Cad), at t
in triplicate.Cephamycin C production and cell growth obtained
at 48 h and 72 h cultivations in basal medium without
additives and supplemented with putrescine, 1,3-diamino-
propane, and cadaverine are shown in Figure 1. Leitão et al.
[32] found that all three diamines promoted cephamycin
C production by N. lactamdurans, albeit at different levels.
The largest increase was observed in culture media con-
taining 2.5 or 5.0 g l-1 of 1,3-diaminopropane. In this
study, this diamine also produced a similar effect: a 100%
increase in volumetric production was observed after the
addition of 5.0 g l-1 of the compound as compared to that
of the culture medium with no additive. Also, the addition
of 1,3-diaminopropane alone promoted higher specific
production than that obtained at the control condition
(Figure 1C). Similarly, Martín et al. [42] observed that
adding 5.0 mM (0.37 g l-1) or 10 mM (0.74 g l-1) of 1,3-
diaminopropane enhanced Penicillium chrysogenum beta-
lactam antibiotic production by approximately 100%. It is




3D (2.5) 1,3D (5.0) Cad (3.5) Cad (7.0)
. Biomass (A), cephamycin C concentration (CephC) (B), and specific
o antibiotic-production enhancing compound (control condition) and
wo concentration values (in parentheses); the cultures were performed
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tion phase [43].
In the present work, putrescine did not affect antibiotic
production by S. clavuligerus (Figure 1B), as Martín et al.
[42,43] observed with P. chrysogenum. However, Leitão
et al. [32] observed positive effects on cephamycin C
production with N. lactamdurans when 0.20 g l-1 of
putrescine was added.
With regard to cadaverine, volumetric production almost
doubled by adding 7.0 g l-1 of this diamine (Figure 1B). How-
ever, specific production was not higher than that obtained
in media without additives (Figure 1C). For cultivations with
N. lactamdurans, a threefold increase was obtained using
5.0 g l-1 of this diamine [32].
In general, the increase in biomass observed at the end
of cultivations (Figure 1A) suggests that these diamines
acted as sources of carbon and energy (C) and/or nitrogen
(N), thereby supplementing the basal medium sources
(starch and PROFLO®).
Cephamycin C production was evaluated at several ly-






















































Figure 2 Effect of biomass and cephamycin C with lysine. Biomass (A)
(C) obtained from batch cultivations in shaken-flasks of basal medium with
and with lysine (Lys) at different concentration values; the cultures were peand 3). Consistent with the literature, high concentrations
of exogenous lysine strongly affected cephamycin C pro-
duction [20,28]. After adding 14.6 g l-1 of this amino acid,
biomass almost doubled (Figure 2A) and cephamycin C
production increased about six fold (Figure 2B) as com-
pared to data from the basal medium. However, residual
concentration values of this amino acid at 14.6 g l-1 and
18.3 g l-1 of lysine were approximately 25% and 35%, re-
spectively. This surplus was not observed at concentra-
tions lower than 11 g l-1. Moreover, a fivefold global
increase in antibiotic volumetric production was obtained
between 0 and 11 g l-1 of lysine, whereas biomass in-
creased only 1.5 times.
Adding up to 1.6 g l-1 of alpha-aminoadipic acid did
not influence biomass formation, which was in the same
order of magnitude as that in the basal medium with no
additives. Adding 0.64 g l-1 of alpha-aminoadipic acid to
the basal medium resulted in the largest increase in cepha-
mycin C production, four times larger than that obtained
with the basal medium. Alpha-aminoadipic acid concen-







, cephamycin C concentration (CephC) (B), and specific production




























































Figure 3 Effect of biomass and cephamycin C with alpha-aminoadipic acid. Biomass (A), cephamycin C concentration (CephC) (B), and
specific production (C) obtained from batch cultivations in shaken-flasks of basal medium with no antibiotic-production enhancing compound
(control condition) and with alpha-aminoadipic acid (AAA) at different concentration values; the cultures were performed in triplicate.
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acid having been completely consumed. Henriksen et al.
[44] reported that alpha-aminoadipic acid can be metabo-
lized into 6-oxo-piperideine-2-carboxylic acid (OPC),
which is secreted into the culture medium during penicil-
lin production by P. chrysogenum. The authors suggested
that OPC formation would divert alpha-aminoadipic
acid from antibiotic synthesis and lead to lower levels of
penicillin production. A similar phenomenon may have
occurred in S. clavuligerus.
Effect of lysine in conjunction with diamines or alpha-
aminoadipic acid on cephamycin C production
The concentration of independent variables enabled the
investigation of ranges in which, according to the litera-
ture and data from this study, it is possible to maximize
cephamycin C production by S. clavuligerus or N. lac-
tamdurans [16,20,21,31-34,42,43]. Based on results of
cultivations using only lysine as additive (Figure 2), con-
centrations of amino acid ranging from 0 to 7.4 g l-1
were selected in order to minimize its effect on biomass
production. With respect to alpha-aminoadipic acid,concentrations ranging from 0 to 0.64 g l-1 were selected
due to superior cephamycin C volumetric production
results obtained in this range (Figure 3).
As to lysine, the highest volumetric production of
cephamycin C was observed at 48 hours, which var-
ied little at 72 hours (Figure 2B). The highest volu-
metric production values for the basal medium with
1,3-diaminopropane or alpha-aminoadipic acid were
observed at 72 hours. With respect to cadaverine and
putrescine, the highest volumetric production values
observed at 48 and 72 hours were almost the same. For
this reason, cultivation time was standardized to 72 hours
for the experimental designs and bioreactor processes.
The chosen experimental design (CCF) and the con-
centration range employed for the compounds under
investigation (independent variables), together with the
use of response surface methodology for statistical treat-
ment of the data obtained at 72 h cultivation, allowed for
the adjustment of quadratic models to predict cephamycin
C production at 90% confidence level. The generated
response surfaces and their corresponding second-order
polynomials are shown in Figure 4. Table 3 shows the
A B
C D
Figure 4 Fitted response surfaces (at 90% confidence level) for cephamycin C concentration (CephC). Batch cultivation (72-hour) in
shaken-flasks in media containing: (A) lysine (Lys) and alpha-aminoadipic acid (AAA), (B) lysine (Lys) and 1,3-diaminopropane (1,3D), (C) lysine
(Lys) and cadaverine (Cad), and (D) lysine (Lys) and putrescine (Put).
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including the F-test to verify the overall significance of
each model, its associated probabilities p(F), and deter-
mination coefficient R2.
Cephamycin C production was affected differently for
lysine combined with the remaining four compounds.
The resulting response surfaces of experimental designs
using lysine and alpha-aminoadipic acid (Figure 4A) and
lysine and 1,3-diaminopropane (Figure 4B) showed curves
and parameters of the same order of magnitude, thereby
providing comparable production values. The adjusted
mathematical models provide the highest cephamycin C
concentrations of approximately 126 and 140 mg l-1 when
0.6 g l-1 of alpha-aminoadipic acid and 5.3 g l-1 of lysine
and 5.2 g l-1 of 1,3-diaminopropane and 7.0 g l-1 of lysine
were added, respectively. In culture media containing
just lysine, a production of about 120 mg l-1 wasobtained, but only at high amino acid concentrations
(14.6 g l-1) (Figure 2).
It should be remarked that alpha-aminoadipic acid has
a strong impact on cephamycin C production even when
added at concentrations nine times lower than those of
1,3-diaminopropane. This is probably due to its being a
direct precursor of the beta-lactam antibiotic molecule
[20,21,33]. On the other hand, 1,3-diaminopropane acts
indirectly on beta-lactam antibiotic biosynthesis at the
genetic and transcriptional levels [32,43]. Leitão et al.
[32] showed that this diamine increases the concentration
of lysine-6-aminotransferase and P6C dehydrogenase,
which are enzymes responsible for alpha-aminoadipic acid
formation. This complex mechanism may support the
need for adding larger amounts of 1,3-diaminopropane to
produce the same effect as that obtained with alpha-
aminoadipic acid at lower concentrations, which is in line
Table 3 Analyses of variance (ANOVA) for the quadratic models regressions at 90% confidence level
Lysine and alpha-aminoadipic acid (R2 = 0.9543*) Lysine and 1,3-diaminopropane (R2 = 0.9544*)
Source SS DF MS F p SS DF MS F p
Model 13,068.14 5 2,613.63 25.06** 6.0 x 10-4 15,993.37 5 3198.67 25.10** 6.0 x 10-4
Residual 625.82 6 104.30 764.58 6 127.43
Lack of fit 509.35 3 169.78 4.37 0.128 441.58 3 147.19 1.37 0.402
Pure error 116.47 3 38.82 323.00 3 107.67
Total 13,693.96 11 16,757.95 11
Lysine and cadaverine (R2 = 0.9793*) Lysine and putrescine (R2 = 0.9006*)
Source SS DF MS F p SS DF MS F p
Model 3,080.16 5 616.03 56.77** <10-4 3,650.07 5 730.01 10.87** 5.7 x 10-3
Residual 65.10 6 10.85 402.82 6 67.14
Lack of fit 32.35 3 10.78 0.99 0.503 318.82 3 106.27 3.79 0.151
Pure error 32.75 3 10.92 84.00 3 28.00
Total 3,145.26 11 4052.89 11
*Coefficients of determination for the regressions at 90% confidence level; SS: Sum of Squares; DF: Degrees of Freedom; MS: Mean Square.
**F(5,6) at 90% confidence level = 3.11.
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those found in the literature clearly demonstrate, albeit
through different methods, that lysine conversion to
alpha-aminoadipic acid is a limiting step to cephamycin C
biosynthesis. For this reason, adding alpha-aminoadipic
acid or 1,3-diaminopropane, though at different concen-
tration levels, was equally effective to overcoming this
bottleneck.
Fitted response surfaces for cultivations in culture
media containing lysine combined with cadaverine indi-
cate that this diamine only exerts influence on antibiotic
production when lysine is added at low concentrations.
When the amino acid concentration was increased, the
effect of adding diamine gradually waned. It has been
suggested that intracellular accumulation of cadaverine
may regulate the lysine catabolic pathway through a
feedback control mechanism. In this manner, the lysine
that would be decarboxylated to form cadaverine is
spared, thus increasing lysine supply for cephamycin bio-
synthesis via the alpha-aminoadipate pathway. The fitted
model shows that this behavior only happens at low lysine
concentrations. At higher concentrations, lysine would
supply both cadaverine and alpha-aminoadipic acid
pathways, thereby decreasing the influence of cadaver-
ine. For this reason, as predicted by the model, there is
little antibiotic variation (73–77 mg l-1 of cephamycin
C) at the highest lysine concentration (7.4 g l-1) within
the entire cadaverine concentration range under investi-
gation. This is due to the fact that the linear effect of
lysine is about thrice stronger than that of this diamine.
With respect to lysine combined with putrescine, adding
0.20 g l-1 of this diamine to media containing 3.7 g l-1 of
amino acid increased production by approximately 40% as
compared to that obtained with medium containing justlysine at the same concentration (Table 2). On the other
hand, adding this diamine to media with higher lysine
concentrations (7.4 g l-1) adversely affected production
due to the negative effect stemming from the interaction
between the compounds (Figure 4D). Thus, the highest
production value predicted for 7.7 g l-1 of lysine combined
with 0.13 g l-1 of putrescine is just 76 mg l-1. Similar volu-
metric production values were obtained with basal culture
media containing 7.4 g l-1 of lysine as additive (Figure 2).
Martín et al. [43] observed that supplementation with
putrescine provided much lower mRNA levels than
those obtained with 1,3-diaminopropane in P. chrysogenum
cultures. Despite structural similarity between 1,3-dia-
minopropane and putrescine, these authors suggest
that the positive effect obtained with diamines is prob-
ably attributable to the three-carbon structure of di-
amines. On the other hand, Leitão et al. [32] observed
an approximately threefold increase when 0.2 g l-1 of
putrescine was added to N. lactamdurans cultures.
Figures 5 and 6 show the results of two cultivations in
bioreactor using 7.0 g l-1 of lysine combined with 5.2 g l-1
of 1,3-diaminopropane and 5.3 g l-1of lysine combined
with 0.64 g l-1 of alpha-aminoadipic acid. These concen-
trations, predicted by the models as optimal production
conditions, resulted in 190 mg l-1 and 160 mg l-1 of
cephamycin C for lysine combined with 1,3-diaminopro-
pane and lysine combined with alpha-aminoadipic acid,
respectively.
When compared to top values predicted by the
mathematical models, these results represent increases
of approximately 35% for lysine combined with 1,3-
diaminopropane and approximately 27% for lysine
combined with alpha-aminoadipic acid. While diamine
supplementation favored cell growth, because it can






















































































































Figure 5 Batch cultivation in agitated and aerated bench-bioreactor for lysine combined with 1,3-diaminopropane. Cephamycin C
concentration (CephC), specific production, and biomass; basal medium containing cephamycin C production-enhancing compounds at their
optimal values (in parentheses), lysine (7.0 g l-1) and 1,3-diaminopropane (5.2 g l-1) (open symbols); control condition: basal medium without
additives (solid symbols).
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http://www.biomedcentral.com/1471-2180/13/296act as an additional source of C and N, alpha-aminoadipic
acid did not affect biomass production. Thus, the
specific production at the end of cultivation with
lysine combined with alpha-aminoadipic acid was
approximately 30% higher as compared to that of
lysine combined with 1,3-diaminopropane, reaching
values of up to 40 mg l-1 and 30 mg l-1, respectively.
Results obtained in bioreactor employing medium
without additives (control condition) are also shown






































Figure 6 Batch cultivation in agitated and aerated bench-bioreactor f
concentration (CephC), specific production, and biomass; basal medium co
optimal values (in parentheses), lysine (5.3 g.l-1) and alpha-aminoadipic acid
additives (solid symbols).Conclusions
It has been known for a long time that adding lysine
enhances cephamycin C production. However, its use as
the sole enhancer does not take full advantage of the
antibiotic productivity of S. clavuligerus. In this study,
an experimental design method (CCF) and Response
Surface Methodology are successfully employed to adjust
mathematical models to describe the effects of lysine com-
bined with cadaverine, putrescine, 1,3-diaminopropane















































































or lysine combined with alpha-aminoadipic acid. Cephamycin C
ntaining cephamycin C production-enhancing compounds at their
(0.6 g.l-1) (open symbols); control condition: basal medium without
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http://www.biomedcentral.com/1471-2180/13/296by S. clavuligerus. Moreover, the interactions observed
and validated by the fitted models are shown to be com-
patible to biochemical data already established in the lit-
erature about the pathway of beta-lactam antibiotics in
S. clavuligerus. This study demonstrates that different
combinations of lysine with other compounds promote
significant variations in antibiotic production, with em-
phasis on the benefits obtained from using lysine combined
with alpha-aminoadipic acid or 1,3-diaminopropane. These
combinations increased cephamycin C production by more
than 100% as compared to that with culture media contain-
ing just lysine as additive at the same concentrations. This
positive effect may be attributed to alpha-aminoadipic acid
or 1,3-diaminopropane in conjunction with lysine acting
to overcome the bottleneck caused by lysine conversion to
alpha-aminoadipic acid, albeit via different mechanisms.
In the case of lysine combined with cadaverine, there was
a positive effect on cephamycin C production by the di-
amine, especially when lysine was added at low concentra-
tions. Cadaverine acted by decreasing lysine catabolism.
However, as the amino acid concentration increased,
the diamine effect waned, as the model clearly indi-
cates. On the other hand, the highest volumetric pro-
duction obtained with lysine combined with putrescine
was approximately twice lower than that obtained with
lysine combined with alpha-aminoadipic acid or 1,3-
diaminopropane.
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